New analysis shows that outcome after surgical treatment of colon cancer improves as the number of lymph nodes removed for examination increases
Analysis of 17 studies from nine countries shows that
outcome after surgery for colon cancer improves as the number of lymph nodes removed
for examination increases, either because a reservoir of potential cancer cells
is removed or because determination of existing spread of disease enables better
postoperative treatment planning, according to an article in the March 21 issue
of the Journal of the National Cancer Institute.
The researchers, from the University of Texas M. D. Anderson
Cancer Center, encourage a dialogue among physicians regarding the number of lymph
nodes removed by surgeons and evaluated by pathologists as a measure of the quality
of care that colon cancer patients receive.
"Currently just over one third of colon cancer patients
in the United States are getting an adequate lymph node evaluation," said
the study's lead author, George Chang, MD, assistant professor in the Department
of Surgical Oncology at M. D. Anderson.
In one of the studies, a national clinical trial of more
than 3,200 patients with Stage II disease designed to examine effects of chemotherapy
on colon cancer recurrence after surgical resection, demonstrated a 14 percent
increase in five-year survival if more than 20 lymph nodes were examined compared
with survival if fewer than 11 nodes were removed. The survival advantage was
even greater - 23 percent - in patients with Stage IIIA and IIIB cancer if more
than 40 nodes were evaluated compared with survival if fewer than 11 nodes were
removed.
All but 1 of 17 studies of Stage II cancer showed the
same association between the number of nodes evaluated and improved outcome, as
did 4 of 6 studies of more advanced cancer.
Chang said, "This tells us that surgeons and pathologists
involved in the care of colon cancer patients should make every effort to improve
their collection and evaluation of lymph nodes."
Sometimes lymph nodes can be difficult for surgeons to
find, especially when they are small or the patient is obese. "Everyone is
different," Chang said. "Some people have more nodes, some people have
fewer; nodes can be large and easy to identify or small, and the number may differ
depending on which part of the colon contains the tumor. The factors that determine
the total number of lymph nodes are not all together known."
Studies have found that 70 percent of colon cancer resections
are performed by general surgeons who do fewer than 10 procedures a year, and
colon cancers removed by surgeons who perform colon cancer surgery more frequently
are more likely to have more lymph nodes examined.
"We are not suggesting surgeons cut out more colon
than necessary, but that they abide to the principals for cancer surgery, and
that pathologists follow up in kind," Chang said.
Because all of the studies examined were observational,
the researchers stress that they cannot definitively say increasing the number
of lymph nodes examined leads to improved survival. Such a statement could only
be supported by a randomized, controlled clinical trial - which would not be ethically
possible.
|